Not applicableUnknownNCT03029013What this trial is testingApatinib and Chemotherapy Sequential Treatment With Cervical CancerWho this might be right forCervical Cancer Third Military Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02111850What this trial is testingT Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 PositiveWho this might be right forCervical CancerRenal CancerUrothelial Cancer+2 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT03439085What this trial is testingDNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated CancersWho this might be right forHuman Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more M.D. Anderson Cancer Center 41
Early research (Phase 1)Ended earlyNCT03277482What this trial is testingDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerWho this might be right forRecurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more Dana-Farber Cancer Institute 16
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299
Testing effectiveness (Phase 2)Ended earlyNCT03367871What this trial is testingCombination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical CancerWho this might be right forCervical Cancer University of Miami 17
Testing effectiveness (Phase 2)UnknownNCT05606263What this trial is testingEfficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Xi'an Jiaotong University 55
Large-scale testing (Phase 3)Looking for participantsNCT06459687What this trial is testingPhase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical CancerWho this might be right forCervical Cancer Lee's Pharmaceutical Limited 440
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237What this trial is testingAK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical CancerWho this might be right forCervical Cancer Akeso 445
Testing effectiveness (Phase 2)UnknownNCT03912402What this trial is testingEfficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)Who this might be right forCervical CancerCervical Cancer MetastaticCervical Cancer Recurrent Biocad 49
Not applicableEnded earlyNCT03786107What this trial is testingHER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of NeratinibWho this might be right forHormone Receptor-Positive, HER2-Negative Metastatic Breast CancerMetastatic Cervical Cancer Puma Biotechnology, Inc. 1,583
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446049What this trial is testingA Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionWho this might be right forLocally Advanced or Metastatic Solid TumorsPTEN Loss or Low Expression Convalife (Shanghai) Co., Ltd. 180
Testing effectiveness (Phase 2)Looking for participantsNCT06172478What this trial is testingHER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaHead and Neck Cancer+11 more Daiichi Sankyo 740
Early research (Phase 1)UnknownNCT05475847What this trial is testingStudy of C-TIL052A Cell Therapy in Advanced Cervical CancerWho this might be right forCervical Cancer Fudan University 20
Large-scale testing (Phase 3)Looking for participantsNCT07216703What this trial is testingA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Who this might be right forCervical Cancer Merck Sharp & Dohme LLC 1,023
Testing effectiveness (Phase 2)Looking for participantsNCT04977453What this trial is testingGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more GI Innovation, Inc. 317
Not applicableTemporarily Not AvailableNCT03842865What this trial is testingExpanded Access of Vigil in Solid TumorsWho this might be right forSolid TumorEwing SarcomaEwing's Tumor Metastatic+5 more Gradalis, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Not applicableActive Not RecruitingNCT04266886What this trial is testingSelf-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic CancerWho this might be right forMalignant Female Reproductive System NeoplasmRecurrent Malignant Female Reproductive System NeoplasmMetastatic Cervical Cancer M.D. Anderson Cancer Center 152